Session V: Presentation of Selected Non-Colorectal Cancer Abstracts
SO-5: Disease-free survival as surrogate for overall survival in neoadjuvant chemo(radio)therapy treatment of esophageal or gastro-esophageal junction carcinoma: an analysis of 4518 individual patients and 22 trials
